Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Prednisolone 2.5 mg gastro-resistant oral tablet |
Has basis of strength substance (attribute) |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Prednisolone 2.5 mg gastro-resistant oral tablet |
Has precise active ingredient |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely prednisolone 5 milligram/1 each gastro-resistant oral tablet (clinical drug) |
Has precise active ingredient |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely prednisolone 5 milligram/1 each gastro-resistant oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Prednisolone (as prednisolone sodium phosphate) 5 mg rectal suppository |
Has basis of strength substance (attribute) |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Prednisolone 50 mg oral tablet |
Has precise active ingredient |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely prednisolone 25 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Prednisolone 1 mg oral tablet |
Has precise active ingredient |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Prednisolone 5 mg oral tablet |
Has precise active ingredient |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Prednisolone 3 mg/mL oral solution |
Has basis of strength substance (attribute) |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Prednisolone 3 mg/mL oral solution |
Has precise active ingredient |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely prednisolone 2 milligram/1 milliliter conventional release oral solution |
Has basis of strength substance (attribute) |
False |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely prednisolone 2 milligram/1 milliliter conventional release oral solution |
Has precise active ingredient |
False |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely prednisolone 1 milligram/1 milliliter conventional release oral suspension (clinical drug) |
Has basis of strength substance (attribute) |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely prednisolone 1 milligram/1 milliliter conventional release oral suspension (clinical drug) |
Has precise active ingredient |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Prednisolone 3 mg/mL oral suspension |
Has precise active ingredient |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Prednisolone 3 mg/mL oral suspension |
Has basis of strength substance (attribute) |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing neomycin and polymyxin B and prednisolone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Prednisolone-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cinchocaine and prednisolone only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Neomycin and polymyxin B and prednisolone only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only neomycin and prednisolone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only gentamicin and prednisolone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only prednisolone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Prednisolone only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Prednisolone only product in rectal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Prednisolone only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Prednisolone only product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Prednisolone only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Prednisolone (as prednisolone sodium phosphate) 5 mg/mL oral solution |
Has basis of strength substance (attribute) |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely prednisolone (as prednisolone sodium phosphate) 10 milligram/1 each conventional release orodispersible tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Prednisolone (as prednisolone sodium phosphate) 3 mg/mL oral solution |
Has basis of strength substance (attribute) |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely prednisolone (as prednisolone sodium phosphate) 15 milligram/1 each conventional release orodispersible tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Prednisolone (as prednisolone sodium phosphate) 1 mg/mL oral solution |
Has basis of strength substance (attribute) |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely prednisolone (as prednisolone sodium phosphate) 30 milligram/1 each conventional release orodispersible tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Prednisolone 25 mg/mL eye suspension |
Has basis of strength substance (attribute) |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Prednisolone 25 mg/mL eye suspension |
Has precise active ingredient |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Prednisolone (as prednisolone sodium phosphate) 5 mg/mL eye solution |
Has basis of strength substance (attribute) |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely prednisolone 1.25 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has basis of strength substance (attribute) |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely prednisolone 1.25 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has precise active ingredient |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Prednisolone (as prednisolone sodium phosphate) 300 microgram/mL eye solution |
Has basis of strength substance (attribute) |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely prednisolone 10 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has precise active ingredient |
False |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely prednisolone 10 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has basis of strength substance (attribute) |
False |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Prednisolone (as prednisolone sodium phosphate) 1 mg/mL eye solution |
Has basis of strength substance (attribute) |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Prednisolone (as prednisolone sodium phosphate) 100 microgram/mL eye solution |
Has basis of strength substance (attribute) |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Prednisolone (as prednisolone sodium phosphate) 10 microgram/mL eye solution |
Has basis of strength substance (attribute) |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Prednisolone (as prednisolone sodium phosphate) 30 microgram/mL eye solution |
Has basis of strength substance (attribute) |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely prednisolone 5 milligram/1 each conventional release orodispersible tablet (clinical drug) |
Has precise active ingredient |
False |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely prednisolone 5 milligram/1 each conventional release orodispersible tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely prednisolone (as prednisolone sodium phosphate) 3 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has basis of strength substance (attribute) |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing prednisolone in oromucosal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Prednisolone only product in oromucosal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cinchocaine and prednisolone only product in rectal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing prednisolone in otic dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Neomycin- and prednisolone-containing product in otic dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Neomycin- and prednisolone-containing product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only neomycin and prednisolone in otic dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Neomycin and prednisolone only product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Prednisolone- and sulfacetamide-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only prednisolone and sulfacetamide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Prednisolone- and sulfacetamide-containing product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Prednisolone and sulfacetamide only product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cinchocaine 1 milligram and prednisolone (as prednisolone sodium phosphate) 1.3 milligram/1 each conventional release rectal suppository (clinical drug) |
Has basis of strength substance (attribute) |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cinchocaine- and prednisolone-containing product in rectal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only prednisolone in otic dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Prednisolone metasulfobenzoate sodium (substance) |
Is modification of (attribute) |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Prednisolone (as prednisolone metasulfobenzoate sodium) 20 mg/actuation rectal foam |
Has basis of strength substance (attribute) |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely prednisolone (as prednisolone sodium phosphate) 5 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely prednisolone (as prednisolone sodium phosphate) 2 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has basis of strength substance (attribute) |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely prednisolone (as prednisolone sodium phosphate) 5 milligram/1 each conventional release orodispersible tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Prednisolone (as prednisolone acetate) 5 mg/g oromucosal paste |
Has basis of strength substance (attribute) |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Serum prednisolone level (procedure) |
Component |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |